KOSEN 한인과학기술자네트워크

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.

Thanks to our world-class researchers, state-of-the-art technologies and unrelenting focus on scientific excellence, Merck is at the forefront of discovering and developing innovative ways to treat and prevent disease.

Before we can develop a new medicine or vaccine, we need to understand the basics. How exactly does the disease or condition work? And how can we potentially alter these underlying processes to help prevent or treat disease?

It takes a long time to identify a potential new treatment. Teams of scientists might screen thousands of molecules to identify a promising lead. That candidate will then need to be refined, optimized and tested in clinical trials before we can apply for regulatory approval.

As part of the initial screening process, our researchers look at many different considerations, including:

• Is the safety profile appropriate for use in patients with a particular disease?
• Does the candidate potentially have the desired effect?
• What is the best means of administration?
• Could it potentially provide improvement over existing options?

A very small fraction of the candidates that begin evaluation will ultimately survive the tough process of research, development and testing to finally become medicines.

We spend billions of dollars each year to identify and develop medicines and vaccines that can help people around the world. Thanks to the talent and tenacity of our researchers ? combined with the scientific and technological advances of the past decade ? we are in an exciting period of discovery at Merck as we continue to seek new and innovative ways to improve health.